] LXRα (Abcam#PPZ0412), H3K27Ac (Abcam#ab4729), NOS‐2 (Santa Cruz#SC‐650 M‐19), ABCA1 (Novus Biologicals #NB400‐105), GAPDH (Abcam #ab9485‐100), Anti‐mouse‐HRP (Santa Cruz#SC‐2005), Anti‐rabbit‐HRP (Santa Cruz#SC‐2004), CD11b‐PerCP‐Cy5.5 (Biolegend #clone M1/70), F4/80‐PE or FITC (Ebioscience #clone BM8), Ly6G‐PE or FITC (BD Pharmingen #clone AL21), MHC‐II‐APC (eBioscience #M5/114.15.2). The following pharmacological reagents were obtained from the MRC PPU Reagents University of Dundee, UK: BI605906 (IKKβ inhibitor), 5Z‐7‐oxozeanol (TAK1 inhibitor), MRT67307 (TBK1 inhibitor) and the following products from Calbiochem: PD0325901 (MEK/ERK inhibitor), PD98059 (MEK1 and MEK2 inhibitor), PIK‐75‐hydrochloride (inhibitor of p110α subunit of PI3‐Kinase), SB590885 (Raf‐1 inhibitor); HX531 (RXR inhibitor). TLR agonists, Poly I:C (TLR3 agonist) and ultrapure LPS from E. coli 0111:B4 strain‐ (TLR4 ligand) were obtained from Invivogen and were used at 10 µg ml−1 and 100 ng ml−1 respectively.
Mhcii apc
MHCII-APC is a laboratory instrument designed for the detection and analysis of major histocompatibility complex class II (MHCII) proteins. It utilizes allophycocyanin (APC) as a fluorescent label to enable the visualization and quantification of MHCII expression on cell surfaces.
Lab products found in correlation
11 protocols using mhcii apc
Macrophage Immunological Profiling
] LXRα (Abcam#PPZ0412), H3K27Ac (Abcam#ab4729), NOS‐2 (Santa Cruz#SC‐650 M‐19), ABCA1 (Novus Biologicals #NB400‐105), GAPDH (Abcam #ab9485‐100), Anti‐mouse‐HRP (Santa Cruz#SC‐2005), Anti‐rabbit‐HRP (Santa Cruz#SC‐2004), CD11b‐PerCP‐Cy5.5 (Biolegend #clone M1/70), F4/80‐PE or FITC (Ebioscience #clone BM8), Ly6G‐PE or FITC (BD Pharmingen #clone AL21), MHC‐II‐APC (eBioscience #M5/114.15.2). The following pharmacological reagents were obtained from the MRC PPU Reagents University of Dundee, UK: BI605906 (IKKβ inhibitor), 5Z‐7‐oxozeanol (TAK1 inhibitor), MRT67307 (TBK1 inhibitor) and the following products from Calbiochem: PD0325901 (MEK/ERK inhibitor), PD98059 (MEK1 and MEK2 inhibitor), PIK‐75‐hydrochloride (inhibitor of p110α subunit of PI3‐Kinase), SB590885 (Raf‐1 inhibitor); HX531 (RXR inhibitor). TLR agonists, Poly I:C (TLR3 agonist) and ultrapure LPS from E. coli 0111:B4 strain‐ (TLR4 ligand) were obtained from Invivogen and were used at 10 µg ml−1 and 100 ng ml−1 respectively.
Flow Cytometric Analysis of Immune Cells
IFNγ , IL-10, TGFβ and TNF (all eBioscience) as well as CXCL1/KC and CXCL2/MIP-2 (both R&D, Minneapolis, USA) were measured from peritoneal lavage and serum by ELISA according to the manufacturers’ protocols and analyzed using a plate reader (Molecular Devices) with SoftMax Pro 6.
Lung Cell Isolation and Immunophenotyping
Dendritic Cell Phenotypic Analysis
Multiparametric Flow Cytometry Analysis
Multicolor Flow Cytometry Analysis of Immune Cells
Generating Bone Marrow-Derived Dendritic Cells
Multiparameter Flow Cytometry Profiling
Cabozantinib Modulates Immune Populations
Characterization of Immune Cell Subsets
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!